TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 1 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 19 | -87.3% | 0.00% | – |
| Q2 2023 | $0 | – | 150 | +581.8% | 0.00% | – |
| Q1 2023 | $0 | – | 22 | -8.3% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | +26.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 19 | -98.1% | 0.00% | – |
| Q2 2022 | $4,000 | -75.0% | 1,019 | -57.7% | 0.00% | – |
| Q1 2022 | $16,000 | -69.8% | 2,411 | -47.8% | 0.00% | – |
| Q4 2021 | $53,000 | +39.5% | 4,615 | +128.8% | 0.00% | – |
| Q3 2021 | $38,000 | +18.8% | 2,017 | +31.7% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 1,532 | +75.1% | 0.00% | – |
| Q1 2021 | $18,000 | +50.0% | 875 | +86.6% | 0.00% | – |
| Q4 2020 | $12,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |